HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.

Abstract
Increasing evidence suggests that the novel anti-inflammatory and proresolving mediators such as the resolvins play an important role during inflammation. However, the functions of these lipid mediators in immune complex-induced lung injury remain unknown. In this study, we determined the role of aspirin-triggered resolvin D1 (AT-RvD1) and its metabolically stable analog, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester (p-RvD1), in IgG immune complex-induced inflammatory responses in myeloid cells and injury in the lung. We show that lung vascular permeability in the AT-RvD1- or p-RvD1-treated mice was significantly reduced when compared with values in mice receiving control vesicle during the injury. Furthermore, i.v. administration of either AT-RvD1 or p-RvD1 caused significant decreases in the bronchoalveolar lavage fluid contents of neutrophils, inflammatory cytokines, and chemokines. Of interest, AT-RvD1 or p-RvD1 significantly reduced bronchoalveolar lavage fluid complement C5a level. By EMSA, we demonstrate that IgG immune complex-induced activation of NF-κB and C/EBPβ transcription factors in the lung was significantly inhibited by AT-RvD1 and p-RvD1. Moreover, AT-RvD1 dramatically mitigates IgG immune complex-induced NF-κB and C/EBP activity in alveolar macrophages. Also, secretion of TNF-α, IL-6, keratinocyte cell-derived chemokine, and MIP-1α from IgG immune complex-stimulated alveolar macrophages or neutrophils was significantly decreased by AT-RvD1. These results suggest a new approach to the blocking of immune complex-induced inflammation.
AuthorsHuifang Tang, Yanlan Liu, Chunguang Yan, Nicos A Petasis, Charles N Serhan, Hongwei Gao
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 193 Issue 7 Pg. 3769-78 (Oct 01 2014) ISSN: 1550-6606 [Electronic] United States
PMID25172497 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 by The American Association of Immunologists, Inc.
Chemical References
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antigen-Antibody Complex
  • CCAAT-Enhancer-Binding Proteins
  • Ccl3 protein, mouse
  • Chemokine CCL3
  • Cytokines
  • Immunoglobulin G
  • NF-kappa B
  • resolvin D1
  • Docosahexaenoic Acids
  • Complement C5a
  • Aspirin
Topics
  • Acute Lung Injury (chemically induced, immunology, pathology, prevention & control)
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal (pharmacology)
  • Antigen-Antibody Complex (immunology)
  • Aspirin (pharmacology)
  • Bronchoalveolar Lavage Fluid (immunology)
  • CCAAT-Enhancer-Binding Proteins (immunology)
  • Cell Line
  • Chemokine CCL3 (immunology)
  • Complement C5a (immunology)
  • Cytokines (immunology)
  • Docosahexaenoic Acids
  • Immunoglobulin G (immunology)
  • Macrophages, Alveolar (immunology, pathology)
  • Mice
  • NF-kappa B (immunology)
  • Neutrophils (immunology, pathology)
  • Pneumonia (chemically induced, immunology, pathology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: